Asahi Kasei to Mass-Produce iPS-Derived Regenerative Medicine Product Nov. 21, 2018 Asahi Kasei Corp. (TYO:3407) is starting to establish infrastructure for manufacturing regenerative medicine products. The company has invested several hundred…... Please subscribe to read the full story. Subscribe Free Trial